Glinta-M Tablet 2.5 mg+500 mg is a combination oral antidiabetic medication containing Linagliptin (2.5 mg) and Metformin Hydrochloride (500 mg). This dual-action therapy is specifically formulated to manage type 2 diabetes mellitus by addressing blood glucose control through complementary mechanisms. Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels, while Metformin improves insulin sensitivity and decreases hepatic glucose production.

By combining these two agents, Glinta-M provides enhanced glycemic control, targeting both fasting and postprandial blood sugar levels, with a low risk of hypoglycemia. It is suitable for patients whose blood sugar is not adequately controlled with diet, exercise, or monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glinta-M Tablet 2.5 mg+500 mg is indicated for:

• Type 2 diabetes mellitus – To improve glycemic control in patients inadequately managed with lifestyle changes alone.

• Combination therapy – Can be used alongside other antidiabetic medications when prescribed by a physician.

• Prevention of complications – Maintaining stable blood sugar helps reduce the risk of diabetes-related cardiovascular, kidney, and nerve complications.

Mechanism of Action

The combination works through two complementary pathways:

• Linagliptin (DPP-4 inhibitor): Inhibits the enzyme DPP-4, increasing incretin hormone levels, which stimulates insulin release after meals and suppresses glucagon secretion to lower postprandial blood glucose.

• Metformin Hydrochloride: Reduces hepatic glucose production, improves peripheral insulin sensitivity, and decreases intestinal glucose absorption, helping control fasting blood sugar levels.

This dual mechanism ensures both postprandial and fasting glucose levels are effectively managed.

Dosage and Administration

• Recommended dose: Typically, one tablet twice daily with meals, or as directed by a healthcare professional.

• Administration: Swallow the tablet whole with water; do not crush or chew to maintain effectiveness.

• Monitoring: Regular blood sugar monitoring is essential to assess efficacy and adjust dosage if required.

Precautions and Warnings

• Kidney or liver impairment: Dose adjustments or caution may be required. Metformin is contraindicated in severe renal impairment.

• Hypoglycemia: Low risk when used alone; may increase if combined with sulfonylureas or insulin.

• Lactic acidosis: Rare but serious; report symptoms like unexplained fatigue, muscle pain, or breathing difficulties immediately.

• Pregnancy and breastfeeding: Use only under medical supervision.

• Drug interactions: Inform your healthcare provider about all other medications being taken.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Mild gastrointestinal discomfort (nausea, diarrhea)

• Headache or dizziness

• Nasopharyngitis (cold-like symptoms)

• Rarely, hypoglycemia, especially with other antidiabetic agents

Adherence to dosing instructions, diet, and lifestyle recommendations helps minimize side effects.

Storage

Store Glinta-M Tablet 2.5 mg+500 mg in a cool, dry place below 25°C, protected from moisture and light. Keep out of reach of children.

Conclusion

Glinta-M Tablet 2.5 mg+500 mg by SK Pharma is an effective dual-action antidiabetic therapy for type 2 diabetes. By combining Linagliptin and Metformin, it provides comprehensive blood sugar control through complementary mechanisms, managing both fasting and postprandial glucose levels. Proper adherence, routine monitoring, and lifestyle modifications ensure safe and effective diabetes management, reducing the risk of long-term complications.